DB18311InvestigationalCell transplant therapies
Taniraleucel: Overview.
- Also known as
- Allogeneic natural killer (NK) cells derived from CD34+ human placental stem/progenitor cells. The cells are expanded and differentiated in the presence of cytokines including thrombopoietin, SCF, Flt3 ligand, IL-7, IL-15 and IL-2 to generate the NK cell · ALLOGENEIC UMBILICAL CORD BLOOD-DERIVED, CULTURE-EXPANDED NATURAL KILLER CELLS
- Code names
- PNK-007
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Taniraleucel, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account